Dorman, S. E., Nahid, P., Kurbatova, E. V., Goldberg, S. V., Bozeman, L., Burman, W. J., . . . Chaisson, R. E. (2020). High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC Study 31/ACTG A5349 phase 3 clinical trial. Contemp Clin Trials.
Chicago-стиль цитированияDorman, Susan E., et al. "High-dose Rifapentine With or Without Moxifloxacin for Shortening Treatment of Pulmonary Tuberculosis: Study Protocol for TBTC Study 31/ACTG A5349 Phase 3 Clinical Trial." Contemp Clin Trials 2020.
MLA-цитированиеDorman, Susan E., et al. "High-dose Rifapentine With or Without Moxifloxacin for Shortening Treatment of Pulmonary Tuberculosis: Study Protocol for TBTC Study 31/ACTG A5349 Phase 3 Clinical Trial." Contemp Clin Trials 2020.